Biodefense |
Biological and Chemical Weapons; Bioterrorism/biodefense |
Biodefense refers to short term, local, usually military measures to restore biosecurity to a given group of persons in a given area — in the civilian terminology, it is a very robust biohazard response. It is technically possible to apply biodefense measures to protect animals or plants, but this is generally uneconomic. However, protection of water supplies and food supplies are often a critical part of biodefense. Various definitions of biosafety emerged in different professions to guar ...
Wikipedia - [full article]
Resources
- Anthrax Fact Sheet (Division of Bacterial & Mycotic Diseases, NCID, CDC, OPHS, HHS)
- Anthrax Vaccine Immunization Program (U.S. Department of Defense)
- Anthrax: What every Clinician Should Know (Public Health Foundation)
- Antrax (Centers for Disease Control and Prevention (CDC))
- Background Information on Anthrax Disease (Centers for Disease Control and Prevention (CDC))
- Biodefense (National Institutes of Health)
- Biodefense -- Links and Publications (National Institute of Allergy and Infectious Diseases)
- Biological Warfare (Mayo Foundation for Medical Education and Research)
- Bioterrorism and CAM: What the Public Needs to Know (National Center for Complementary and Alternative Medicine)
- Botulism (National Institute of Allergy and Infectious Diseases)
- Botulism: Frequently Asked Questions (Division of Bacterial & Mycotic Diseases, NCID, CDC, OPHS, HHS)
- Ciprofor Inhalation Anthrax - Information for Consumers (Center for Drug Evaluation and Research, FDA, OPHS, HHS)
- Clinical and Epidemiologic Principles of Anthrax (National Center for Infectious Diseases, CDC, OPHS, HHS)
- DisasterHelp (U.S. Department of Homeland Security)
- Facts About Anthrax, Botulism, Pneumonic Plague, and Small Pox (Centers for Disease Control and Prevention (CDC))
- Factsheet: Anthrax (National Institute of Allergy and Infectious Diseases)
- Factsheet: Botulism (National Institute of Allergy and Infectious Diseases)
- Factsheet: Plague (National Institute of Allergy and Infectious Diseases)
- Factsheet: Smallpox (National Institute of Allergy and Infectious Diseases)
- Factsheet: Study Seeks to Determine Effectiveness of Diluted Smallpox Vaccine (National Institute of Allergy and Infectious Diseases)
- Factsheet: Tularemia (National Institute of Allergy and Infectious Diseases)
- FDA Public Health Advisory: Update on Use of Doxycycline for Antrhax Exposure (Food and Drug Administration, HHS)
- FEMA: Fact sheet - Terrorism (Federal Emergency Management Agency)
- Frequently Asked QuestionsAbout Ricin (Centers for Disease Control and Prevention (CDC))
- HHS Fact Sheet- Questions and Answers about Anthrax Prevention and Treatment (U.S. Department of Health and Human Services)
- How to Handle Anthrax and Other Biological Agent Threats (Centers for Disease Control and Prevention (CDC))
- Interim Recommended Notification Procedures for Local and State Public Health Department Leaders in the Event of a Bioterrorist Incident (Centers for Disease Control and Prevention (CDC))
- National Pharmaceutical Stockpile (Centers for Disease Control and Prevention (CDC))
- NIAID Biodefense Research (National Institute of Allergy and Infectious Diseases)
- NIAID Biodefense Research Agenda for Category A Agents (National Institute of Allergy and Infectious Diseases)
- NIAID Biodefense Research Agenda for Category B and C Priority Pathogens (National Institute of Allergy and Infectious Diseases)
- NIAID Blue Ribbon Panel on Bioterrorism and Its Implications for Biomedical Research (National Institute of Allergy and Infectious Diseases)
- NIAID Category A, B & C Priority Pathogens (National Institute of Allergy and Infectious Diseases)
- NIAID High Priority Biodefense Products (National Institute of Allergy and Infectious Diseases)
- NIAID Strategic Plan for Biodefense Research (National Institute of Allergy and Infectious Diseases)
- Plague (National Institute of Allergy and Infectious Diseases)
- Public Health Emergency Preparedness: Transforming (U.S. Department of Health and Human Services)
- Q&A: An Integrated Research Facility at Fort Detrick, Maryland (National Institute of Allergy and Infectious Diseases)
- Q&A: Building 33, an Integrated Research Facility for the NIH Campus (National Institute of Allergy and Infectious Diseases)
- Rocky Mountain Laboratories Integrated Research Facility (National Institute of Allergy and Infectious Diseases)
- Smallpox.gov - Smallpox Information website, U.S. Department of Health and Human Services (U.S. Department of Health and Human Services)
- Study Seeks to Determine Effectiveness of Diluted Smallpox Vaccine (National Institute of Allergy and Infectious Diseases)
- Summary of NIAID Accomplishments in Biodefense Research (National Institute of Allergy and Infectious Diseases)
- Tularemia (National Institute of Allergy and Infectious Diseases)
- Use of Anthrax Vaccine in the United States (Centers for Disease Control and Prevention (CDC))
- What Is Anthrax? (Kids Health)

Not Signed In -


